These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36310817)

  • 1. Antimicrobial resistance and COVID-19: Intersections and implications.
    Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI
    Elife; 2021 Feb; 10():. PubMed ID: 33588991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability.
    Sharma S; Chauhan A; Ranjan A; Mathkor DM; Haque S; Ramniwas S; Tuli HS; Jindal T; Yadav V
    Front Microbiol; 2024; 15():1403168. PubMed ID: 38741745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.
    Ansari S; Hays JP; Kemp A; Okechukwu R; Murugaiyan J; Ekwanzala MD; Ruiz Alvarez MJ; Paul-Satyaseela M; Iwu CD; Balleste-Delpierre C; Septimus E; Mugisha L; Fadare J; Chaudhuri S; Chibabhai V; Wadanamby JMRWW; Daoud Z; Xiao Y; Parkunan T; Khalaf Y; M'Ikanatha NM; van Dongen MBM;
    JAC Antimicrob Resist; 2021 Jun; 3(2):dlab038. PubMed ID: 34192258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health systems appraisal of the response to antimicrobial resistance in low- and middle-income countries in relation to COVID-19: Application of the WHO building blocks.
    Patel J; Fernandes G; Mwamelo AJ; Sridhar D
    Glob Policy; 2023 Nov; 14(5):790-796. PubMed ID: 38504997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions.
    Cocker D; Birgand G; Zhu N; Rodriguez-Manzano J; Ahmad R; Jambo K; Levin AS; Holmes A
    Nat Rev Microbiol; 2024 Jul; ():. PubMed ID: 39048837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's Hot in Clinical Infectious Diseases? 2019 IDWeek Summary.
    Moss S; Boucher HW
    Open Forum Infect Dis; 2020 Apr; 7(4):ofaa104. PubMed ID: 32352020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Canadian Institutes of Health Research response to antimicrobial resistance.
    Pagé EL; Desnoyers S; Létourneau IJ; Keown K; Jackson A; Ouellette M
    Can Commun Dis Rep; 2015 Nov; 41(Suppl 5):11-15. PubMed ID: 29769970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population surveillance of cardiovascular diseases in low-income to middle-income countries should leverage existing international collaborations.
    Echouffo-Tcheugui JB; Yaya S; Joshi R; Narayan KMV; Kengne AP
    BMJ Glob Health; 2018; 3(5):e000866. PubMed ID: 30294457
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance.
    Boccabella L; Palma EG; Abenavoli L; Scarlata GGM; Boni M; Ianiro G; Santori P; Tack JF; Scarpellini E
    Antibiotics (Basel); 2024 Feb; 13(3):. PubMed ID: 38534668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022.
    Altorf-van der Kuil W; Wielders CC; Zwittink RD; de Greeff SC; Dongelmans DA; Kuijper EJ; Notermans DW; Schoffelen AF;
    Euro Surveill; 2023 Dec; 28(50):. PubMed ID: 38099348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre.
    Gavi F; Fiori B; Gandi C; Campetella M; Bientinesi R; Marino F; Fettucciari D; Rossi F; Moretto S; Murri R; Pierconti F; Racioppi M; Sacco E
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antimicrobials during the COVID-19 pandemic: A qualitative study among stakeholders in Nepal.
    Dhungel B; Thapa Shrestha U; Adhikari S; Adhikari N; Bhattarai A; Pokharel S; Karkey A; Limmathurotsakul D; Ghimire P; Rijal KR; Cheah PY; Pell C; Adhikari B
    PLOS Glob Public Health; 2023; 3(11):e0002166. PubMed ID: 37963156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.
    Gulumbe BH; Sahal MR; Abdulrahim A; Faggo AA; Yusuf ZM; Sambo KH; Usman NI; Bagwai MA; Muhammad WN; Adamu A; Aminu U; Abubakar MT; Lawan KA
    Health Sci Rep; 2023 Sep; 6(9):e1566. PubMed ID: 37711678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived
    Kokkini M; Oves-Costales D; Sánchez P; Melguizo Á; Mackenzie TA; Pérez-Bonilla M; Martín J; Giusti A; de Witte P; Vicente F; Genilloud O; Reyes F
    Mar Drugs; 2023 Aug; 21(8):. PubMed ID: 37623724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of the COVID-19 pandemic on antimicrobial use in companion animals in an academic veterinary hospital in North Carolina.
    Jolley A; Love W; Frey E; Lanzas C
    Zoonoses Public Health; 2023 Aug; 70(5):393-402. PubMed ID: 37029504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution characterization of the dynamic conjugative entry exclusion protein TraG.
    Bragagnolo N; Audette GF
    Struct Dyn; 2022 Nov; 9(6):064702. PubMed ID: 36590369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten ways to make the most of World Antimicrobial Awareness Week.
    Langford BJ; Matson KL; Eljaaly K; Apisarnthanarak A; Bailey PL; MacMurray L; Marra AR; Simonsen KA; Sreeramoju P; Nori P; Bearman GM
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e187. PubMed ID: 36425221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance-An expert review.
    Seneghini M; Rüfenacht S; Babouee-Flury B; Flury D; Schlegel M; Kuster SP; Kohler PP
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e27. PubMed ID: 36310817
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.